Safety comparison of additives in antiglaucoma prostaglandin (PG) analog ophthalmic formulations

PURPOSE: To investigate the safety of five types of antiglaucoma prostaglandin analog ophthalmic formulations, and to clarify their differences in accordance with contained additives (preservatives and surface-active agents). METHODS: The following five types of ophthalmic solutions and three types...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Fukuda, Masamichi, Shibata, Shinsuke, Shibata, Naoko, Hagihara, Kenta, Yaguchi, Hiromoto, Osada, Hiromi, Takahashi, Nobuo, Kubo, Eri, Sasaki, Hiroshi
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2013
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3601024/
https://ncbi.nlm.nih.gov/pubmed/23515900
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OPTH.S40147
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados